Skip to main content

NORGES BANK

Bank

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1374170 OSLO, Q8

Position in HALO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$116,125,128
-$12,076,122 QoQ
Shares Held
1,483,648
-22.1% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 667 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. HALO ranks #19 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $116,125,128 1,483,648
2025-12-31 $128,201,250 1,904,922
2025-06-30 $45,026,847 865,568
2025-03-31 $53,227,239 834,152
2024-12-31 $60,054,332 1,256,104
2024-09-30 $62,408,371 1,090,293
2024-06-30 $63,678,189 1,216,161
2024-03-31 $50,462,563 1,240,476
2023-12-31 $44,934,822 1,215,769
2023-09-30 $48,450,970 1,268,350
2023-06-30 $45,483,548 1,260,980
2023-03-31 $41,611,824 1,089,600
2022-12-31 $53,956,619 948,271
2022-09-30 $39,104,625 988,989
2022-06-30 $54,284,164 1,233,731
2022-03-31 $47,284,320 1,185,665
2021-12-31 $42,067,621 1,046,198
2021-09-30 $41,684,023 1,024,681
2021-06-30 $36,670,391 807,540
2021-03-31 $50,004,570 1,199,438
2020-12-31 $48,546,107 1,136,645
2020-09-30 $27,519,102 1,047,150
2020-06-30 $32,399,187 1,208,474
2020-03-31 $27,498,146 1,528,524